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Abstract
Identifying the genes causing male infertility is important to increase our biological understanding as well as the diagnos-
tic yield and clinical relevance of genetic testing in this disorder. While significant progress has been made in some areas, 
mainly in our knowledge of the genes underlying rare qualitative sperm defects, the same cannot be said for the genetics 
of quantitative sperm defects. Technological advances and approaches in genomics are critical for the process of disease 
gene identification. In this review we highlight the impact of various technological developments on male infertility gene 
discovery as well as functional validation, going from the past to the present and the future. In particular, we draw attention 
to the use of unbiased genomics approaches, the development of increasingly relevant functional assays and the importance 
of large-scale international collaboration to advance disease gene identification in male infertility.
Introduction
Infertility is a complex pathological condition that affects 
close to 7% of the global male human population and pre-
sents as a wide range of heterogeneous phenotypes, from 
congenital or acquired urogenital abnormalities, endocrine 
disturbances and immunological factors to spermatogenic 
quantitative and qualitative defects (Krausz 2011; Tour-
naye et al. 2017). While severe forms of infertility cannot 
be directly inherited—by default an affected man is incapa-
ble of naturally passing on his genetic information (unless 
facilitated by assisted reproductive technologies)—genetics 
plays a major role in this disorder. Unaffected parents can 
for example pass on genetic mutations that result in autoso-
mal recessive or X-linked forms of male infertility (Chillón 
et al. 1995; Yatsenko et al. 2015). In addition, many muta-
tional events take place during normal gametogenesis that 
can result in germline de novo mutations (DNMs), de novo 
copy number variations (CNVs) or de novo chromosomal 
abnormalities, some of which can result in male infertility 
in the offspring (Jacobs and Strong 1959; Reijo et al. 1995; 
Sun et al. 1999).
In approximately 15% of infertile men a genetic defect is 
most likely the underlying cause of the pathology (Tournaye 
et al. 2017; Krausz and Riera-Escamilla 2018). However, 
despite widespread usage of karyotyping, azoospermia fac-
tor (AZF) deletion screening and cystic fibrosis transmem-
brane conductance regulator (CFTR) mutation analysis, a 
recent study in a large unselected patient cohort revealed a 
causal genetic diagnosis in only 4% of infertile men (Tüttel-
mann et al. 2018). Similar to what has been found for other 
disorders, genetics is found to play a more prominent role 
in the most severe forms of spermatogenic impairment such 
as severe oligozoospermia (< 5 million sperm cells per ml) 
or azoospermia (no sperm in ejaculate) (Lopes et al. 2013; 
Krausz and Riera-Escamilla 2018).
The identification of genetic causes of male infertility, 
which began in the middle of the twentieth century, contin-
ues to this day aided by the development of novel molecu-
lar techniques and technological advancements that have 
allowed for the discovery and characterisation of key genes 
responsible for the various subtypes of human male infertil-
ity (Fig. 1). Although evidence for a genetic cause of male 
infertility was first reported in the 1950s, when an extra X 
chromosome was found in patients diagnosed with Kline-
felter Syndrome, it was not until the late 1990s that research 
efforts were intensified to search for additional genetic 
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factors, initially focusing on specific deletions and muta-
tions in the androgen receptor and the CFTR gene (Dumur 
et al. 1990; Akin et al. 1991; McPhaul et al. 1992; Patrizio 
et al. 1993) and Y chromosomal abnormalities (Vogt et al. 
1992; Reijo et al. 1995). In recent years, researchers have 
increasingly applied array-based genome-wide approaches 
and, more recently, next-generation sequencing (NGS) 
technologies to perform more unbiased genomic studies in 
male infertility and identify numerous male infertility genes 
(Aston and Carrell 2009; Talkowski et al. 2011; Tüttelmann 
et al. 2011; Ayhan et al. 2014).
In this review, we contextualise how different technologi-
cal advances have contributed to our understanding of the 
genetics of male infertility, detailing current shortcomings 
and challenges. We conclude by providing some perspective 
on future directions and a call-to-arms among researchers, 
clinicians and patients for stronger collaboration and sharing 
of information for the benefit of all.
The past: chromosome studies and specific 
gene analysis revealed the first male 
infertility genes
Chromosomal abnormalities causing male infertility
Karyotyping was the first test employed to investigate the 
presence of genetic abnormalities in infertile men and to this 
day remains the most widely used diagnostic test in male 
infertility. This cytogenetic technique revealed several very 
important chromosomal abnormalities associated to male 
infertility, with the most common being the presence of an 
additional X chromosome (47, XXY) which characterises 
Klinefelter syndrome (Jacobs and Strong 1959), present in 
15% of non-obstructive azoospermic patients (Ferlin et al. 
2006a; Jungwirth et al. 2012; Punab et al. 2016; Vockel et al. 
2019). The combination of karyotype analysis with fluo-
rescence in situ hybridisation (FISH) revealed additional 
chromosomal abnormalities to underlie primary infertility 
and sex development disorders, specifically 46, XX male; 
Robertsonian and reciprocal translocations (Therkelsen 
1964; Chapelle et al. 1964; Hamerton 1968; Koulischer and 
Schoysman 1974; Jacobs et al. 1975).
Karyotype analysis was also essential to identify the loca-
tion of genetic factors controlling normal spermatogenesis. It 
was through the usage of this technique that in 1976 a dele-
tion at the distal portion of band q11 of the Y chromosome 
was found in 6 men with azoospermia and the region was 
identified as essential for spermatogenesis (Tiepolo and Zuf-
fardi 1976). Although this pointed to the presence of a gene 
or genes controlling human spermatogenesis in this deleted 
portion of the Y chromosome, it was not until the 1990s that 
the first gene directly involved in spermatogenic failure was 
identified by novel molecular technologies.
The search for the azoospermia factor (AZF) within the 
deleted regions of the Y chromosome involved the use of 
polymerase chain reaction (PCR) analysis and Y-specific 
sequence-tagged sites (STSs) to identify potential candi-
date genes (Ma et al. 1992, 1993; Kobayashi et al. 1994). 
Appropriately, the strongest candidate gene found to be 
Fig. 1  Timeline of the discovery of key genes involved in male infer-
tility. The development of novel molecular techniques and techno-
logical advancements introduced since 1956 have allowed for the 
identification of key genes responsible for the various types of male 
infertility in humans. Although the first male infertility genes were 
first identified in the late 1980s, the widespread application of micro-
array and NGS approaches has resulted in an increase in the detection 
of male infertility genes
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absent in the azoospermic men with Y microdeletions was 
named Deleted in Azoospermia or DAZ (Reijo et al. 1995, 
1996; Vogt 1998; Ferlin et al. 1999), of which four paralogs 
(DAZ1-4) have now been identified on the Y chromosome 
(Saxena et al. 2000). Further application of these PCR-
based techniques revealed three genomic regions on the Y 
chromosome frequently deleted in men with spermatogenic 
failure, named AZF regions a, b, and c (Vogt 1998). Each 
of these regions contains candidate genes highly or exclu-
sively expressed in the testis and essential in spermatogen-
esis, including BPY2, CDY, DAZ, HSFY, RBMY, PRY, TSPY; 
VCY and XKRY (Reijo et al. 1995; Elliott et al. 1997; Lahn 
and Page 1997; Yen 1998; Sun et al. 1999; Skaletsky et al. 
2003; Krausz and Casamonti 2017). Microdeletions affect-
ing AZF regions result in a variable phenotype, ranging from 
oligozoospermia to azoospermia in 2–10% in infertile men 
(Krausz and Riera-Escamilla 2018). However, the genetic 
causes for the infertility of most men remained unknown, 
requiring scientists to look elsewhere in the genome.
Identification of specific gene mutations resulting 
in male infertility
The first gene linked to male infertility outside of the Y 
chromosome was identified in 1988 on chromosome X. At 
the time, mutations in the murine androgen receptor gene, 
mapped via linkage analysis to the X chromosome, had 
already been well established to cause testicular feminisation 
in mice (Lyon and Hawkes 1970). Based on this information, 
Brown et al. used a PCR-based approach coupled with south-
ern blotting to reveal that deletion of the human Androgen 
Receptor (AR, also known as NR3C4) was responsible for 
infertility in patients with mild or partial androgen insen-
sitivity syndrome, as well as sex reversal in patients with 
complete androgen insensitivity syndrome (Brown et al. 
1988). Initially, PCR-amplified exons of the AR gene were 
screened for mutations using techniques such as denatur-
ing gradient gel electrophoresis (DGGE) and single-strand 
conformational polymorphism analysis (SSCP) and by dena-
turing high performance liquid chromatography (DHPLC) 
screening (Quigley et al. 1995; Ferlin et al. 2006b). Since 
the gene was first linked to male infertility, mutations in AR 
have been identified in 2% of infertile men causing either 
mild or partial androgen insensitivity syndrome (McPhaul 
et al. 1992; Ferlin et al. 2006b; Gottlieb et al. 2012; Vockel 
et al. 2019).
In 1989, mutations in the CFTR gene (Cystic Fibrosis 
Transmembrane Conductance Regulator) on chromosome 
7 were discovered to underlie Cystic Fibrosis, using restric-
tion fragment length polymorphism (RFLP) analysis to 
pinpoint the genomic locus of interest followed by PCR-
based sequencing to identify mutations (Kerem et al. 1989; 
Riordan et al. 1989). Since the original reporting, further 
studies have identified specific mutations in this gene 
responsible for isolated infertility. In particular, mutations 
in CFTR have been found to cause obstructive azoospermia 
as a result of Congenital Bilateral Absence of the Vas Defer-
ens using DGGE and SSCP techniques (Dumur et al. 1990; 
Anguiano 1992; Culard et al. 1994). The high prevalence 
of CFTR mutations in the global population, particularly 
in individuals of European descent where 1 in 25 are carri-
ers of pathogenic variants, explains why CFTR gene muta-
tions cause 60–70% of congenital absence of the vas defer-
ens (CAVD) cases (Weiske et al. 2000). Overall, however, 
CAVDs is a rare condition found in only 1–2% of all infertile 
men (Bieth et al. 2020).
Optimization and upscaling of Sanger sequencing on 
automated DNA sequencers resulted in wide-scale adoption 
of DNA sequencing in human disease research and diagnos-
tics in the early 2000s (Metzker 2005; Hutchison 2007). It 
was particularly successful in testing for mutations in can-
didate disease genes identified by either positional cloning 
or by evidence from orthologous genes studied in model 
organisms. A good example of this was shown by the identi-
fication of mutations in SYCP3 gene related to meiotic arrest 
during spermatogenesis (Miyamoto et al. 2003). The role of 
this gene in male infertility had been previously established 
in mice where male homozygous null mutants for the Sycp3 
gene were found to be infertile due to massive apoptotic cell 
loss during spermatogenesis (Yuan et al. 2000). After isola-
tion of the human SYCP3 gene it was found to have an iden-
tical function and similar negative consequences to human 
fertility if disrupted (Martinez-Garay et al. 2002; Miyamoto 
et al. 2003). Of note, while in mice bi-allelic mutations are 
required to reveal an infertility phenotype, in humans a sin-
gle heterozygous mutation in SYCP3 is sufficient to compro-
mise spermatogenesis.
The present: technological advances 
allowing unbiased analysis of the infertile 
genome
Genome‑wide homozygosity screening using 
microsatellite scans and SNP microarrays
Adaptations made to existing sequencing technology as well 
as the introduction of single nucleotide polymorphism (SNP) 
microarrays in the 1990s permitted once more a shift in the 
research approaches available to investigate the genomes of 
infertile men and identify novel genes associated with male 
infertility. Initially, this work was focused on developing 
and applying large sets of polymorphic markers to screen 
genomes of infertile men from consanguineous descent for 
regions of homozygosity. In 2007, this new positional clon-
ing approach resulted in the identification of two novel male 
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infertility genes, AURKC and SPATA16, causing multiple 
morphological sperm abnormalities (Dieterich et al. 2007; 
Dam et al. 2007). Similarly, homozygosity mapping was 
used to identify an homozygous variant in DNAH1 in a small 
cohort of infertile men with morphological abnormalities in 
their sperm flagella (Ben Khelifa et al. 2014).
Microarray‑based detection of genomic copy 
number variation
While structural variants such as CNVs present on the Y 
chromosome have been clearly shown to have a negative 
effect on spermatogenesis (Nathanson et al. 2005; Visser 
et al. 2009; Krausz and Casamonti 2017), only few other 
structural genomic variations have been robustly linked to 
male infertility. Microarray-based comparative genomic 
hybridization (array CGH) and SNP arrays have dramatically 
increased the detection resolution of genomic deletions and 
duplications since the late 90 s (Solinas-Toldo et al. 1997; 
Pinkel et al. 1998).
The application of SNP microarray technology revealed 
one important CNV associated with male infertility in 2011, 
a 200 kb homozygous deletion affecting the DPY19L2 gene 
(Harbuz et al. 2011; Koscinski et al. 2011). Specific ampli-
fication and sequencing of DPY19L2 was initially ham-
pered by the presence of a pseudogene. In 2012, Coutton 
et al. optimized the conditions to specifically amplify and 
sequence this gene and identified globozoospermia patients 
with a combination of a deletion and a nonsense or mis-
sense mutation, as well as a patient with homozygous mis-
sense mutations (Coutton et al. 2012). Together, deletions 
and point mutations in DPY19L2 are now known to explain 
most cases of globozoospermia.
In 2011, Tüttelmann et al. employed microarray technol-
ogy to discover an excess of rare CNVs on the sex chromo-
somes of azoospermic and severe oligozoospermic German 
men (Tüttelmann et al. 2011), a signature that was later 
replicated in other populations (Stouffs et al. 2012; Krausz 
et al. 2012; Lopes et al. 2013; Lo Giacco et al. 2014). More 
recently, high-resolution array-CGH was used by Yatsenko 
et al. to identify an identical deletion of three exons of the 
TEX11 gene on chromosome X in two patients with azoo-
spermia. Sanger sequencing of this gene revealed additional 
pathogenic (truncating and splice) mutations in azoospermia 
patients (Yatsenko et al. 2015). Mutations in TEX11 were 
also reported in azoospermia patients by another group in 
the same year (Yang et al. 2015). Interestingly, this group 
decided to study TEX11 because they previously showed that 
male mice lacking this gene show meiotic arrest, resulting 
in azoospermia (Yang et al. 2008).
Using a similar microarray approach, recurrent deletions 
affecting the DMRT1 gene located on chromosomes 9 have 
been associated with azoospermia (Lopes et al. 2013; Lima 
et al. 2015). While putative pathogenic mutations in azoo-
spermic men have also been described in this gene (Tewes 
et al. 2014), it’s role in infertility is still not completely 
clear. The clinical relevance of other rare CNVs, reported 
in a limited number or even a single infertile man, remains 
uncertain. As an example, an approximately 1 Mb deletion 
found in a single azoospermic man was reported in 2014. 
The CNV on chromosome 11 spans nine genes, of which 
the WT1 gene was hypothesized as the potential cause for 
spermatogenic failure (Seabra et al. 2014). Another example 
involves an 11–15 kb deletion on chromosome X observed 
so far exclusively in azoospermic men from the Mediterra-
nean, causing a partial deletion of the proximal copy of the 
MAGEA9B gene (Lo Giacco et al. 2014; Shen et al. 2017).
While SNP and CGH microarrays have highlighted the 
important role of CNVs in male infertility, the widespread 
application of next-generation sequencing (NGS) now offers 
the opportunity to combine the detection of CNVs and other 
more complex structural variations with the simultane-
ous detection of SNVs (Zhou et al. 2018; Ho et al. 2019). 
Recently, a balanced reciprocal translocation affecting the 
SYCP2 gene was reported in a patient with severe oligo-
zoospermia, initially discovered by karyotyping but further 
characterized using both microarrays as well as NGS (Schilit 
et al. 2020). Interestingly, through international collabora-
tion, loss-of-function mutations affecting this gene were 
identified in an additional three infertile patients from Ger-
many, highlighting the importance of combining structural 
genomic variation and single nucleotide variation analysis 
as well as multi-institutional collaboration.
Next‑generation sequencing to detect new disease 
genes
The development of high-throughput NGS platforms in 
the past decade has resulted in a dramatic drop in sequenc-
ing costs and an equally dramatic increase in sequencing 
throughput. Rather than relying on the need to select and 
sequence individual candidate genes or evaluate specific pol-
ymorphisms or large structural defects in a small number of 
patients and controls, NGS allows for unbiased sequencing 
of large numbers of genes, all coding exons (whole exome 
sequencing) or sequencing of the entire human genome, and 
increasingly allows this to be done in very large cohorts of 
patients and controls. Accordingly, NGS has provided an 
inexpensive and rapid genetic screening approach to dis-
cover novel disease-associated genes (Boycott et al. 2013; 
Fernandez-Marmiesse et al. 2018). Figure 2 shows how in 
recent years exome sequencing has become the predominant 
technology used for disease gene studies in male infertility.
In Multiple Morphological Abnormalities of the Sperm 
Flagella (MMAF), exome sequencing of relatively small 
cohorts of patients has been particularly successful, resulting 
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in the identification of many important new recessive dis-
ease genes (Touré et al. 2020). Exome sequencing has also 
been successfully applied to identify new disease genes for 
patients with acephalic spermatozoa. In particular, homozy-
gous and compound heterozygous mutations in testis-spe-
cific genes BRDT, SUN5 and PMFBP1 (Zhu et al. 2016, 
2018; Li et al. 2017; Sha et al. 2019) have been found to dis-
rupt the head-flagella junction of the spermatozoa of these 
infertile men. In addition, NGS has also been instrumental 
in the study of congenital isolated hypogonadotropic hypo-
gonadism, characterised by incomplete or absent puberty 
and infertility. A large number of pathogenic mutations have 
been identified in genes and genetic loci that result in neu-
rodevelopmental defects of gonadotropic hormone-releasing 
hormone (GnRH) neuron migration or disrupt neuroendo-
crine GnRH secretion and action (Cangiano et al. 2020; Butz 
et al. 2020).
The investigation of the genetic basis for the much more 
common forms of non-obstructive azoospermia has proven 
to be more difficult, likely because of the enormous genetic 
heterogeneity resulting in a wide diversity of phenotypes 
encompassed in NOA, from the complete lack of germ cells 
(Sertoli cell only syndrome) to various forms of maturation 
arrest. Nevertheless, significant progress has been made on 
this front, where exome sequencing of azoospermic men 
in both consanguineous and non-consanguineous families 
has revealed pathogenic mutations in genes such as TEX15 
(Okutman et al. 2015), FANCM (Kasak et al. 2018), XRCC2 
(Yang et  al. 2018), MEIOB (Gershoni et  al. 2019) and 
FANCA (Krausz et al. 2019). In addition, exome sequencing 
revealed mutations in ADGRG2 in patients with congenital 
obstructive azoospermia (Patat et al. 2016). In conclusion, 
the widespread application of exome sequencing in azoo-
spermia and severe oligozoospermia is uncovering muta-
tions in many new candidate disease genes (see also Kasak 
and Laan 2020). At this stage, however, many of these new 
candidate genes have not been independently replicated and 
their role in quantitative sperm defects therefore remains to 
be established.
Clinical validity assessment of candidate infertility 
genes
Up to this point we have described the different approaches 
used to identify genetic variants associated with male infer-
tility. However, in order to convincingly link variants in a 
certain gene to disease, one needs to consider various levels 
of evidence. Incorrect and misleading conclusions about 
the role of genes in causing quantitative or qualitative sper-
matogenic defects could lead to inappropriate diagnoses and 
even mismanagement and counselling of couples. Further-
more, incorrectly characterized genes may impede follow-up 
research by contaminating candidate disease gene lists and 
pathway analyses. It is therefore important to identify genes 
with insufficient, inconclusive and low-quality evidence for 
involvement in the aetiology of male infertility. Recently, 
a systematic clinical validity assessment of all evidence 
available for gene-disease relationships in male infertility 
was performed (Oud et al. 2019). Based on a previously 
published method (Smith et al. 2017), 92 genes were clas-
sified as at least moderately linked to a human male infer-
tility phenotype. This included only 18% of all 521 gene-
disease relationships described in male infertility at that 
Fig. 2  Breakdown of genetic tools used in published male infertility 
studies over the past decade. Based on an analysis of all published 
literature related to monogenic forms of male infertility, Sanger 
sequencing was the predominant tool used (82%) in 2010 but has 
since then seen a reduced usage down to 26% in 2019. In the same 
time period, NGS-based techniques gained ground to become cur-
rently the most common tool (61%)
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time, demonstrating that the quality and extent of evidence 
varies greatly.
In the years to come, the number of novel genes described 
for male infertility is expected to increase rapidly as NGS 
methods become even more widely and frequently used. It 
is therefore important to continue adding and regularly re-
assessing the genetic and functional evidence for all genes 
described (Soraggi et al. 2020; Houston et al. 2020).
Recent developments in functional validation
The proper design of functional validation experiments, as 
well as reliance on previously developed functional mod-
els with male infertility phenotypes, are critical for the 
validation of newly identified variants. The emergence of 
new techniques for gene editing and the implementation of 
novel model organism and in vitro systems for the study of 
spermatogenesis has and will continue to expand our ability 
to perform the critical step of functional validation (Fig. 3).
In many diseases, in vitro modelling systems are widely 
used and highly effective in screening large numbers of 
variants across multiple genes. Additionally, in many cases 
in vitro systems can be established from individuals carrying 
a specific variant, enabling the direct assessment of the func-
tional impact of the variant. However, despite significant 
efforts, the development of in vitro spermatogenesis systems 
in humans has proven elusive to date (Komeya et al. 2018). 
The ability to culture and maintain the function of human 
Fig. 3  Mutagenesis techniques for functional validation and exam-
ples in male infertility research. Outline of the current mutagenesis 
techniques for functional validation, and the approximate year of 
application. Comparison of the main characteristics of the described 
techniques and some published examples of the application of these 
technologies in male infertility research
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testicular tissue would enable the functional validation of 
novel variants, and perhaps the modification of variants that 
cause azoospermia, potentially enabling the restoration of 
spermatogenic capacity in the not-too-distant future (Sato 
et al. 2011; Ibtisham et al. 2017).
While in vitro systems are not well established for the 
study of male infertility, the application of gene editing 
tools in a variety of model organisms has proven effective 
in the functional validation of suspected infertility-causing 
variants. For example, in the mouse, N-ethyl-N-nitrosou-
rea (ENU), an alkylating agent that induces genome-wide 
mutagenesis at random loci (Lewis et al. 1992; Stainier et al. 
2017), has been successfully used for the identification of 
novel genes required for male fertility. Following random 
mutagenesis by ENU, mice displaying an infertility pheno-
type are subsequently screened by a variety of approaches, 
including selective breeding and linkage analysis, and more 
recently whole genome sequencing, to identify the mutations 
underlying reproductive defects (Kennedy and O’Bryan 
2006; Jamsai and O’Bryan 2010; Geister et al. 2018).
In cases where a candidate variant has been identified 
and requires functional validation, a variety of targeted 
approaches can nowadays be applied. These approaches 
include the use of morpholino oligonucleotides for relatively 
short-term suppression of gene activity, zinc finger nucle-
ases (ZFN), transcription activator-like effector nucleases 
(TALEN) and Clustered regularly interspaced short palin-
dromic repeats (CRISPR) (Summerton 1999; Gaj et al. 2013; 
Rumi et al. 2014; Ramanagoudr-Bhojappa et al. 2018; Anuar 
et al. 2019), which enable genomic modification to inactivate 
a gene through the introduction of a premature stop codon 
or frameshift mutation. Alternatively, these approaches can 
be used to recapitulate specific mutations, for example a 
missense mutation that is predicted to be pathogenic (Gaj 
et al. 2013; Anzalone et al. 2019). While all of these tools 
have been applied successfully in male infertility research, 
the advantages of CRISPR in terms of cost, efficiency and 
simplicity have made this gene editing technology the tool 
of choice for most contemporary studies, and its use in male 
infertility research will certainly expand rapidly in the com-
ing years.
The enormous value of mouse knock-out experiments for 
the identification of human male infertility genes has already 
been highlighted in early studies (Lyon and Hawkes 1970; 
Yuan et al. 2000). For example, studies of the murine Klhl10 
gene, shown to be essential for spermiogenesis in mice, moti-
vated male infertility studies in humans and pointed to one of 
the few known examples of autosomal dominant male infer-
tility (Yan et al. 2004). After employing reverse-transcription 
PCR on RNA isolated from sperm of infertile and healthy 
men, two pathogenic-predicted KLHL10 missense mutations 
and one splicing mutation were identified by Sanger sequenc-
ing in severely oligozoospermic patients. Of note one fertile 
man was found to harbour one of these missense mutations, 
questioning the penetrance of this variant (Yatsenko et al. 
2006). Another example is hsf2, which was initially found to 
regulate normal spermatogenesis in mice (He et al. 2003) and 
it was only later that dominant negative heterozygous muta-
tions in the human orthologue HSF2 were found in infertile 
men by targeted NGS sequencing of this and ~ 600 other infer-
tility candidate genes (Mou et al. 2013).
Zebrafish have been used increasingly to model human dis-
eases including infertility. Lin et al. showed using a zebrafish 
model and Crispr/Cas9 that the amh gene is essential to control 
the balance between proliferation and differentiation of male 
germ cells (Lin et al. 2017). More recently CRISPR technol-
ogy was used to systematically characterize the function of 
17 Fanconi Anemia (FA) genes, revealing their essential role 
in growth, sexual development and fertility (Ramanagoudr-
Bhojappa et al. 2018). Studies like these are essential for the 
clinical validity assessment of genes related to male infertility 
and provide additional evidence for the role of recently identi-
fied mutations of these genes in azoospermic men (Kasak et al. 
2018; Krausz et al. 2019).
High throughput screens in Drosophila using ethyl-meth-
anesulfonate-induced mutations, similar to the ENU approach 
in mice (Wakimoto et al. 2004) or more recently RNA interfer-
ence (RNAi) knockdown (Yu et al. 2015) enabled the efficient 
identification of candidate infertility genes and downstream 
functional assessment of multiple candidate genes in a sin-
gle experiment. For example, discovery of the role of boule 
(homologous to human DAZ) in meiosis was first discovered 
in a large-scale mutation screen using drosophila (Castrillon 
et al. 1993; Eberhart et al. 1996).
Lastly, flagellated and ciliated unicellular organisms includ-
ing Chlamydomonas, Trypanosoma and Tetrahymena have 
been used to study the functional consequences of mutations in 
genes involved in sperm flagellar formation and function (e.g. 
CFAP43, CFAP44, ODA7, SPAG16L, and WDR66) in patients 
displaying MMAF (Zhang et al. 2006; Duquesnoy et al. 2009; 
Coutton et al. 2018; Kherraf et al. 2018). Yeast have likewise 
been an important model organism for the study of meiosis, 
enabling the identification of novel meiotic genes associated 
with male infertility, for example gda1 -orthologous to human 
ENTPD6 (Wang et al. 2015).
The use of gene editing tools in these and other model 
organisms will continue to be important in identifying and 
characterizing genetic variants associated with male infertility.
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The future: overcoming existing limitations 
to improve biological understanding, 
patient diagnostics and prognostics
The introduction of unbiased NGS approaches have revo-
lutionized the identification of genetic causes for many 
diseases (Payne et al. 2018; Bean et al. 2020). Although 
these methods are frequently used in research laboratories 
to study the genetics of male infertility, they have yet to 
identify the majority of genes underlying this disorder. For 
several types of male infertility such as DFS-MMAF, ace-
phalic sperm syndrome and globozoospermia, the current 
diagnostic yield based on known genetic causes explains 
approximately 50% of cases. In contrast, the diagnostic 
yield for the most common forms of male infertility, azoo-
spermia and oligozoospermia, remains much more limited 
(Krausz 2011; Tüttelmann et al. 2018; Krausz and Riera-
Escamilla 2018). Given the enormous potential of new 
genomic technologies in both research and diagnostics, 
how can we most efficiently improve our understanding of 
the genetics of male infertility? To conclude this review, 
we will discuss the limitations and pitfalls of current 
approaches and highlight some important new develop-
ments in genomic technologies and improvements in the 
organization of our research that should help to accelerate 
disease gene identification.
Challenges to gene discovery in a relatively common 
heterogeneous disorder
Exome and especially genome sequencing now allow us 
to perform unbiased genetic studies that can help to iden-
tify novel disease genes or genomic regions. The power to 
discover novel infertility genes is, however, still heavily 
influenced by a number of study design considerations. 
As with other disease models, careful phenotyping and 
cohort selection are critical. In addition, an understanding 
of the genetic architecture of the disease is important in 
designing appropriately powered studies. As previously 
discussed, discrete sperm morphological abnormalities are 
expected to involve a relatively modest number of genes, 
whereas a quantitative spermatogenic failure phenotype 
may arise from variants in any one of hundreds or even 
thousands of genes. In the case of extremely rare disorders 
with discrete phenotypes, a small case/control design may 
be appropriate, as it is likely that variants will be localized 
to a small number of genes. Genetic studies in consan-
guineous families have proven to be an effective means 
of identifying novel male infertility genes accounting for 
rare qualitative sperm defects. In cases of consanguinity, 
analyses can be focussed on regions of the genome that are 
homozygous by descent, as it is likely that rare recessive 
disease-causing mutations will exist in a homozygous state 
more frequently in these families (Okutman et al. 2015; 
Kasak et al. 2018).
In the investigation of NOA in outbred populations, it 
is likely that individual genes will harbour disease-causing 
variants at extremely low frequency in the patient popu-
lation, given the effect of the disease on overall fitness. 
In this case, large patient and control cohorts and robust 
statistical methods are essential to identify genes with an 
increased mutational load in the genome of affected patients, 
as was shown for other genetically heterogeneous disorders 
(Fitzgerald et al. 2015; Wilfert et al. 2016). This calls for 
large-scale collaborative studies and widespread data shar-
ing to reliably and robustly identify and functionally validate 
new male infertility genes.
International consortia have recently been established in 
the field of male infertility genetics to promote this, includ-
ing the GEMINI consortium (https ://gemin i.conra dlab.org/) 
and the IMIGC consortium (https ://www.imigc .org/). Col-
laboration, both within and beyond these consortia, will 
be essential to identify recurrently mutated genes, study 
detailed clinical presentations, perform relevant functional 
studies to confirm the pathogenicity of certain mutations and 
unravel the underlying biological mechanisms. Moreover, 
these consortia can help to replicate single case observations 
and confirm or question the role of new candidate genes in 
infertility, establish clinical guidelines and help to improve 
genetic diagnostics. Increased research collaboration can be 
a driver that benefits both our biological understanding as 
well as patient diagnostics in the field of male infertility.
Establishing the role of inherited and de novo 
mutations in infertility
So far, most research has focused on studying either auto-
somal recessive or X/Y-linked forms of male infertility. 
Severe male infertility cannot be dominantly inherited from 
fathers, but it can be maternally inherited or caused by de 
novo germline and post-zygotic mutations or CNVs. Exome 
and genome sequencing of patient-parent trios has revealed 
the importance of de novo germline mutations in many spo-
radic genetic diseases, in particular in intellectual disability 
and related disorders (Vissers et al. 2010, 2016; Veltman and 
Brunner 2012; McRae et al. 2017). This approach can be 
an immensely powerful means of identifying novel disease 
genes, but one of the main challenges for applications in 
male infertility research is that parental DNA samples are 
often unavailable. Recently, however, several groups have 
started to assemble cohorts of patient-parent trios for male 
infertility genetic research, aiming to identify de novo muta-
tions causing male infertility as well as providing insight 
into dominant maternal inheritance.
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variation in male infertility
Most NGS approaches use short-read sequencing which 
limits the detection of repeat structures (Schatz et  al. 
2010), highly homologous sequences and structural vari-
ation (Zhou et al. 2018; Ho et al. 2019). This affects male 
infertility research significantly, given the importance of 
chromosome microdeletions in highly homologous and 
repetitive regions on the Y chromosome as well as causal 
structural variation reported in other genomic regions. 
Recently, new sequencing platforms have emerged that 
have increased sequencing read lengths from a few hun-
dred nucleotides to 10 kb or even longer (Rhoads and Au 
2015; Gordon et al. 2016; Jiao et al. 2017). Because of 
their increased read length these platforms are much better 
able to detect repeat expansions, homologous sequences 
and structural genomic variation (Pendleton et al. 2015; 
Cretu Stancu et al. 2017). Unfortunately, the current per-
base accuracy and cost of these technologies does not 
yet compare favourably to short-read sequencing meth-
ods (Rhoads and Au 2015; Rang et al. 2018). Therefore, 
it is not yet possible to reliably and affordably ascertain 
all genetic variation present in the genome of an infertile 
patient in a single experiment. However, complete, accu-
rate and affordable human genome sequencing will likely 
be available in the next decade, and the major challenge 
in male infertility will become variant interpretation, not 
detection.
Conclusion
Significant progress has been made in our understanding of 
the genetics of male infertility. Using a variety of genomic 
technologies, the genes involved in rare qualitative sperm 
defects have now been largely identified, resulting in the 
development and application of NGS gene panels with a 
high diagnostic yield. Progress in our understanding of the 
genetics underlying the more common quantitative sperm 
defects has not been as rapid as we have seen in qualitative 
sperm defects or in other genetic disorders. The organi-
zation of large well-funded consortia studying thousands 
of patients with unbiased genomics approaches and the 
application of relevant functional validation assays should 
result in a much-needed breakthrough in this field in the 
coming years.
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